Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.
about
Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infectionsAcinetobacter baumannii: evolution of antimicrobial resistance-treatment optionsResistance mechanismsCarbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast AsiaResponse to Bile Salts in Clinical Strains of Acinetobacter baumannii Lacking the AdeABC Efflux Pump: Virulence Associated with Quorum SensingAnticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter InfectionsGlobal regulator SoxR is a negative regulator of efflux pump gene expression and affects antibiotic resistance and fitness in Acinetobacter baumanniiAn outbreak of blaOXA-51-like- and blaOXA-66-positive Acinetobacter baumannii ST208 in the emergency intensive care unit.Identification of Acinetobacter baumannii serum-associated antibiotic efflux pump inhibitors.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.In vitro and in vivo analysis of antimicrobial agents alone and in combination against multi-drug resistant Acinetobacter baumannii.Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump.A novel method of consensus pan-chromosome assembly and large-scale comparative analysis reveal the highly flexible pan-genome of Acinetobacter baumanniiPrevalence of Genes of OXA-23 Carbapenemase and AdeABC Efflux Pump Associated with Multidrug Resistance of Acinetobacter baumannii Isolates in the ICU of a Comprehensive Hospital of Northwestern ChinaContribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumanniiQuorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme.Analysis of the role of the LH92_11085 gene of a biofilm hyper-producing Acinetobacter baumannii strain on biofilm formation and attachment to eukaryotic cellsIn Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii.Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.More Than Just Light: Clinical Relevance of Light Perception in the Nosocomial Pathogen Acinetobacter baumannii and Other Members of the Genus Acinetobacter.A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.Development of a rapid diagnostic assay based on magnetic bead purification of OXA-β-lactamase mRNA.Intravenous Minocycline: A Review in Acinetobacter Infections.The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates.Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.Phenotype microarray analysis of the AdeRS two-component system in Acinetobacter baumannii.Single amino acid substitution Gly186Val in AdeS restores tigecycline susceptibility of Acinetobacter baumannii.Contribution of TetB Efflux Pump on Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii.Studies on Acinetobacter baumannii involving multiple mechanisms of carbapenem resistance.Spatial molecular epidemiology of carbapenem-resistant and New Delhi metallo beta-lactamase (blaNDM)-producing Escherichia coli in the piglets of organized farms in India.Emergence of Hospital Acquired Carbapenem Resistant Non-Fermenters in Teaching Institute.Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii.Molecular Characterization of Reduced Susceptibility to Biocides in Clinical Isolates of Acinetobacter baumannii.Multiple substitutions lead to increased loop flexibility and expanded specificity in Acinetobacter baumannii carbapenemase OXA-239.Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade.Relationship between tolerance and persistence mechanisms in Acinetobacter baumannii strains with AbkAB Toxin-Antitoxin system.Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects.Prevalence of Acinetobacter baumannii bacteremia in intensive care units of Ibn Rochd University Hospital, Casablanca.Proteogenomic characterization of antimicrobial resistance in extensively drug-resistant Acinetobacter baumannii DU202.Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.
P2860
Q26991886-4686452C-E9D5-479B-9C4E-DEEF5ADF6E30Q27015109-C633E5C6-9B61-4565-A04E-09E89D583A6CQ28069941-30D61331-FA25-4858-A8CE-EE68757C01AEQ28078775-C1EFC035-E283-40EC-BB3B-FF8259A2A169Q33652749-6EB49C1C-8657-4FC1-B27D-83493F6AC1A8Q33732524-09914610-5351-4A51-863E-66E48C03933EQ33818174-3FD95251-068D-4D6A-A136-F4DD33A75AC9Q34406204-25854570-C37D-415A-A62A-F185354A046AQ34596864-2CC1D57B-4E5E-4446-9663-ACC227F20313Q35482558-E8D10A7F-5B2F-41CC-ACDA-446178CA8C5CQ35650658-F3C7006E-7943-437C-A1DC-9F3AEA8828F0Q35859953-87A49AE2-9441-49A9-AED5-5C07D9413922Q35865965-CEC5632C-C6E8-4843-8675-31D16604E49DQ36013058-E86B4A0D-181B-4442-9A31-75F9CCFEF45DQ36035894-8B923681-ECD0-4AB4-A416-C7910104A446Q36318434-4970F4C8-79F6-4DC8-B3BE-49E48CC501D9Q36913299-44927AB2-D26A-4A5B-9BF5-A25E25EA07FAQ37023110-3957EE60-C91D-43B0-ABC7-9EB7B3FD9328Q38269145-85377AFE-ACB2-4C28-AF26-8555DD2BA503Q38572833-D2592A6E-D8ED-4E40-B34B-C4BF1CF96DBFQ38817442-CE8DE4A0-2DA0-4CB5-8297-4FDFA3403A90Q38869114-B7187977-582E-4C62-9226-582B983336D9Q38940459-24B62EF5-3E9B-4871-8586-ACE26FD3DD8FQ39024870-491DC0CB-34B0-4759-B3C3-8E6C00BBB8EBQ39218893-D4FE80EC-7043-4175-8D1F-07E914F4FAD9Q39498405-011079E8-B251-4463-A9BC-1EC9325C691AQ39498417-C461FE47-7CCC-487C-A994-22D233BEF8C5Q40121777-36436E0B-EDBC-40A1-A100-AECDE515B61BQ40166767-055C1B41-59C4-4E17-A825-A1A9EE5E1D59Q40272790-A53F1647-B70B-4C58-98F0-85BEEB15DDF4Q40329500-A01ED210-DC06-47C4-954C-6AC3910AA71CQ41168091-BB63B1FE-3869-408E-938D-1EC3C98E3EEFQ42368408-353383B4-AE15-4641-A33F-3D8F80496699Q47305062-3F49B0E4-F2C9-45A5-8641-C168E338B55BQ48095816-C642E0FD-84E5-4BC4-9EEB-9DDF40631E6AQ49792019-B9729CC7-752E-43E5-8920-A9302472A6FCQ50134161-D621AFB1-7388-4B45-8F6A-3942C827D0C9Q50318336-A44034E7-EC52-4BCF-9D25-3B2C4C393C62Q53297389-EFCDF806-58CF-433D-B1AD-68C0E3F6C064Q55109762-D6922072-3B43-4E41-8214-74AFCEED13E1
P2860
Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contribution of efflux pumps, ...... es of Acinetobacter baumannii.
@en
Contribution of efflux pumps, ...... es of Acinetobacter baumannii.
@nl
type
label
Contribution of efflux pumps, ...... es of Acinetobacter baumannii.
@en
Contribution of efflux pumps, ...... es of Acinetobacter baumannii.
@nl
prefLabel
Contribution of efflux pumps, ...... es of Acinetobacter baumannii.
@en
Contribution of efflux pumps, ...... es of Acinetobacter baumannii.
@nl
P2093
P2860
P50
P356
P1476
Contribution of efflux pumps, ...... tes of Acinetobacter baumannii
@en
P2093
C Ruiz de Alegría
F Fernández-Cuenca
J M Cisneros
Spanish Group of Nosocomial In ...... o Antimicrobials (GEIH-GEMARA)
Spanish Network for Research in Infectious Diseases(REIPI)
Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)
P2860
P304
P356
10.1128/AAC.00730-13
P407
P50
P577
2013-08-12T00:00:00Z